Category Archives: Spotlight Interviews

Nigel Brown: Founder, Inventor, Ideas man, Outdoor lover…

Nigel Brown2

Dr Nigel Brown is the Founder Director of Arvia Technology – a company based in north-west England which has patented an innovative method of removing micro-pollutants from water.

Dr Brown’s extensive scientific knowledge combined with practical experience make him one of the world’s leading authorities on the removal of micro pollutants from water and wastewater.

Trained in chemical engineering and environmental engineering, Dr Brown has had a far-reaching global career in the water industry which has included work in India, Canada, China, Italy and the US.

After university he spent 7 years as an international water and effluent troubleshooter for Foseco, ensuring the company fulfilled its obligations on  water treatment around the world. He then joined as Process Engineering Manager for Simon Hartley Limited, a company specialising in the manufacture and design of effluent plants and equipment. Later, as an independent consultant he specialised in water management and wastewater treatment – which sparked his interest in improving traditional methods of removing toxic chemicals.

The technology at the core of Arvia was developed at the University of Manchester, where Dr Brown, working with Dr Ted Roberts, was a research fellow in the department of Chemical Engineering and Analytical Science.

 

  1. What are you looking forward to explaining to the audience?

What I get excited about is the journey from initial research in my garage laboratory through academic research at the University of Manchester to the creation of Arvia Technology to exploit it. It is describing both how the technology works and the benefits that this can give to potential customers.

  1. Why did you decide to do a webinar with Business Review Webinars?

In our search for a webinar company to help us share our message, Business Review Webinars have shown to deliver a wide cross section of high quality and interested participants from across the globe.

  1. What has been the best moment in your career?

I think the best moment was the decision to go independent and work as a researcher and consultant. The ability to undertake my own research and find the means to support that was an exciting time. It was the initial stages of what was to become Arvia Technology.

  1. What’s the best book you’ve ever read and would recommend?

The Lord of the Rings has to be the best book I have ever read. The vastness of the storyline combined with the imagination and creativity. It is just epic!

  1. What motivates you?

To me it’s the application of knowledge. Taking all the research I do from an idea and being able to apply it to solve real problems. I like to sit on the academic and industrial interface and try to apply new ideas to solve problems.

6. Why are you particularly interested in the environmental side of things?

I particularly enjoy the outdoors so being able to address environmental issues is a real driver. The impact of humans on the environment is becoming increasingly significant, anything we can do to mitigate that is worthwhile.

7. What are you looking to achieve in the future in your personal and professional life?

In my professional life it is to see further large scale Arvia installations extending the process into disinfection, which is an exciting new development. Personally, the cost of getting the kids through university will be a major achievement.

8. How did you get into the industry and what do you most enjoy about your role?

By chance I worked with a company that assigned me a project in the water industry, which made me the company expert in this area. I was then given lots of other water problems to solve, which I very much enjoyed. The research side of the role is the most enjoyable. Being able to play in the lab is precious time, so it would be great to have more time to do that, but at this stage the main thing is to share what problems Arvia can already solve.

9. What has been your best holiday and where would you recommend visiting?

Victoria Falls in Zimbabwe. That was so fantastic I have been 3 times. You get drenched with the spray. As its so wet there is rainforest all around and the water creates an amazing mist.

10. What’s the most useful thing someone has taught you?

There is nothing stopping you pursuing your goals. Continue doing what you want to, until told otherwise. Senior Engineer I worked with in my first job called David Wilks.

Nigel will be presenting in Arvia’s webinar ‘Pharma Wastewater Solutions: the next era of trace level organics removal‘ on the 8th July at 3pm London/10am New York. You can register for the webinar here.

Linda Zellner, Project Manager Bioplastics Perstorp

LLinda Zellnerinda Zellner is Project Manager, Innovation – Materials and others at Perstorp, a position she has held since 2011, when she joined Perstorp. She coordinates cross-functional innovation projects within Green chemistry and Bioplastics, working with internal and external partners on a global level. Her main responsibilities include project planning, developing marketing strategies and creating new competitive products within the targeted segments.

Why did you decide to do a webinar with Business Review Webinars?

It is an excellent opportunity to reach out to many different industries at the same time that are working with Bioplastics. A webinar is a very efficient tool to use and by doing so we can save time and money – not only for us but for our customers too. It’s a win win!

We can cover many topics and answer questions live which give it an additional dimension compared to downloading a presentation or answering questions in emails.

What are you looking forward to explaining to the audience?

I would like to explain and highlight the benefits of our Bioplastic offer to the represented industries in the forum and cover the most important topics for these products. I hope to answer many questions to facilitate the decision making as well as the product development within different application areas among the listeners. And of course also create an interest for our Capa™ for Bioplastics portfolio.

What do you most enjoy about your role?

The role as a Project Manager in Bioplastics enables me to influence and contribute to the development of new materials with a lower environmental impact. I believe that sustainability is the key for a better future. Every day in my work is different. I work with so many different areas as well as people making this role very dynamic and exciting which fits my personality perfectly. On top of this, to combine the technical activities with marketing – that is the perfect setup for getting feedback from the outside, to ensure that we are focusing on the right things – meaning what the customer wants and needs!

 Where is your favourite place in the world and why?

I would say anywhere if it’s underwater – amazing marine life, the sound of the ocean (no cell phones or any other disturbing noises), the feeling of being weightless, I can let my thoughts just fly around in my head and relax. I just love it!

If I have to pick a place underwater – then it will be Malapascua or Donsol in the Philippines with an incredible marine life. A place on land – exotic Koh Lanta in Thailand or a big city like San Francisco with its great scenery. What I pick depends on my state of mind.

Lately I think and worry about of these places and dive spots more and more since I often see them being contaminated with plastics. To eliminate this contamination, bioplastics will be a part of the solution and in my work I can help to find these solutions – I can be a part of closing the loop!

Linda will be presenting the Perstorp Webinar ‘Learn how to improve your bioplastics performance’ on 29th June at 3PM London/10AM New York – Register for the webinar here

Piritta Maunu, Life Science Regulatory Expert, Vaisala

Piritta MaunuPiritta Maunu is a Life Science Regulatory Expert in Vaisala. She has long experience in biotechnology, having worked in several quality management positions in R&D, quality and GMP production. Piritta holds a degree of M.Sc. (Cell Biology) and has studied teaching with a specialty in General Biology. In her role at Vaisala, she creates informational content for life science customers and provides application support to R&D teams creating solutions for monitoring critical environments. Additionally, she provides training through webinars and seminars to both internal groups at Vaisala and to industry contacts.

1. Why did you decide to do a webinar with Business Review Webinars?

Through webinars we want to share the vast amount of knowledge that Vaisala experts have about measurement and monitoring of regulated environments. Business Review Webinars have proven to be a good platform for reaching out to the different players in the life science industry.

2. What are you looking forward to explaining to the audience?

I will discuss the chain of actions you need to understand and perform when storing supplies and products in warehouses regulated by Good Distribution Practices (GDP). These regulations tell you to perform a mapping study before storing any products in the storage areas. However, they don’t necessarily give you any practical guidance. In the webinar we go through some reference documents explaining what should be done as part of a mapping study. I will also give some advice on how to select the locations of sensors or data loggers for a monitoring system, and how the changes in the Annex 15 affect your mapping qualification and monitoring system software validation work. And last but not least, I will discuss some simple risk assessment principles that should provide help in validation of a monitoring system software.

3. What do you most enjoy about your role?

I enjoy working as a regulatory expert and meeting professionals within the field of life science. As I also have a degree in teaching biology, I find teaching people new skills very rewarding.

4. What would someone be surprised to know about you?

I studied music before taking my degree in cellular biology and teaching. During that time I played traditional Finnish instrument called “kantele” (it is similar to zither) as well as harp. The musical conservatory was located quite far away from my home, so I used to drive there by motorbike. My friends called me the motorcycling harpist.

5. What do you do in your leisure time to relax?

I like sports, as well as hiking and observing the wonders of the nature. I also enjoy fishing and picking berries. As my kids play soccer, it is part of my leisure time as well – watching the games and travelling around the country for the tournaments.

Piritta will be presenting Vaisala’s webinar ‘The Impact of 2015 Revisions to EU GMP Annex 15 on GDP’ on the 25th June at 3pm London/10am New York. You can register for the webinar here.

Warren Ward-Stacey, Sales Director, PRISYM ID

Warren Ward-Stacey

Warren is responsible for leading and driving results from the global sales team. He has a detailed knowledge of the auto-ID industry with particular emphasis on label lifecycle management and production techniques.

Warren is passionate in identifying and securing new business opportunities, whilst building business within our existing global client base to create year on year revenue growth.

1. Why did you decide to do a webinar with Business Review Webinars?

We know from talking with clients and prospects alike that many are facing increasing challenges with FDA/EU regulatory compliance in their labeling operations.  Combined with the continued drive for improving supply chain efficiency, this means current labeling systems are often not sufficient.   Implementing a new labeling system can often seem a complex task so we wanted to highlight ways to reduce the impact of this, and ensure it’s done in the most efficient way.

2. What are you looking forward to discussing with the audience?

Hopefully we’ll be able to show the audience how they can reduce the perceived validation pain of implementing a labeling lifecycle management solution, ensuring they are compliant with all relevant regulations, but also making the labeling process more efficient – reduce risk, reduce process costs and improve compliance!

3. What has been the best moment in your career?

There have been many! I think one of the best would be helping a medical device client realize savings of around $8M through supporting their move to print-on-demand.  This meant they could dramatically reduce the amount of paper wastage by printing country specific IFU’s.  It saved them around 175 tonnes of paper wastage, which has to be good for the environment too!

4. Where is your favourite place in the world and why?

Sri Lanka…. Great people, good culture and cricket!!

Warren along with his colleage Chas Kelley will be presenting PRISYM ID webinar ‘Keeping Your Labeling System Ahead of the Curve’ on the 9th June at 3pm London/10am New York. You can register for the webinar here.

 

Bend Research (a division of Capsugel Dosage Form Solutions): Jeff Breit, Director & Brandon Downey, Technical Group Leader

bend

Jeff Breit & Brandon Downey will describe efforts at Bend Research to develop integrated biotherapeutic manufacturing hardware and software technologies to reduce risk and optimize their clients’ fed-batch and perfusion processes. Register here.

 

1. Why did you decide to do a webinar with us?

We spent some time evaluating webinar vendors and felt that Business Review Webinars offered the right audience for our content, as well as an advanced platform designed to engage the audience.

Response from Phoenix Barringer, Marketing Manager at Bend Research, a division of Capsugel Dosage Form Solutions

2. What are you looking forward to explaining to the audience? 

We are currently developing a bioprocess definition platform based on a fundamental understanding of input/output relationships and system dynamics.  This platform is enabled by an integrated laboratory setting, which contains automated sampling handling hardware combined with PAT technology and large data set reduction software tools.  A case study will be presented that highlights the capabilities of the lab and a bioprocess development methodology that focuses on increasing product quality and streamlining the product development critical path.

Response from Jeff Breit, Director at Bend Research, a division of Capsugel Dosage Form Solutions

3. How did you get into the industry?

Bend Research has a track record of scientific and engineering excellence in the pharmaceutical development space.  Our clients requested that we leverage our engineering and biological expertise to better understand and consider optimizing practices in biologics manufacturing.  Since venturing into this space approximately 8 years ago, we have advanced certain technologies, often with development partners, in order to streamline and ensure direct application in upstream and downstream manufacturing practices.  Recently, we have focused our efforts on integration, data reduction and prediction, as these capabilities and technologies are needed to advance next generation processes in fed batch, perfusion and continuous manufacturing.

Response from Jeff Breit, Director at Bend Research, a division of Capsugel Dosage Form Solutions

4. Why are cell response dynamics important for developing a feed or control strategy in a bioreactor?

We are using cell responses to generate the right kind of data to build a predictive model showing how the inputs, like feeds, affect the outputs, such as titer and product quality. A predictive model of this type can help to develop a feeding strategy through predictive optimization, and by increasing process understanding of how the selected inputs affect the product outputs. A predictive model can also be used in a model predictive controller for active control of product outputs.

Response from Brandon Downey, Technical Group Leader at Bend Research, a division of Capsugel Dosage Form Solutions

5. In regards to PAT integration in your lab, how are your selecting analytical tools and how are you using the data sets that are produced?

Analytical tools measure the product outputs that are important from a quality perspective. Essentially, whatever needs to be controlled should be measured. The most important product quality measurements may vary from product to product, but the underlying methodology is the same.

Response from Brandon Downey, Technical Group Leader at Bend Research, a division of Capsugel Dosage Form Solutions

Join Jeff & Brandon in Bend Research’s webinar ‘Innovative, PAT-Integrated Bioprocess Environment’ on 3 June at 4pm London/11am New York.

Gene Tetreault, Sr. Director, Products and Marketing for the Laboratory Informatics Portfolio

Gene LI

In this role Gene is providing the vision, strategy and management of the laboratory informatics product portfolio that includes the Electronic Laboratory Notebook, Laboratory Information Management System and the Laboratory Execution system.


Gene has been working in the Life Science industry for over 20 years developing robotic and Laboratory informatics systems.

 

 1. What are you looking forward to discussing with the audience?

The focus of our discussion will be the typical challenges that come along with paper based and/or disconnected processes in the Quality Testing context. We will give an overview of the possibilities and capabilities of the BIOVIA Quality Testing solution and show the benefits of moving to an electronic Quality Testing solution. We will also analyze how they can tie into contributing to the overall goals of an organization.

2. You’ve mentioned that quality operations are typically a bottleneck and considered to include many non-value add activities for the drug manufacturing process. Can you explain why?

Studies at drug manufacturing companies have shown that the average time for Quality Control/Quality Assurance activities is typically almost double the time an organization spends on actual production processes. This is largely due to organizations relying on paper based and disconnected processes which are difficult to manage and make adherence to regulations more challenging and resource consuming. In addition, many quality testing systems are not integrated with an inventory solution making even more manual data entry work. These inefficiencies lead to non-value add waiting times for the release of raw materials used in the production process as well as to waiting and high inventory costs by a delayed release of finished products.

3. Is this topic only relevant for roles that are directly engaged in working with Quality Testing?

Quality Testing should actually be seen in the larger context of an organization’s Total Quality Strategy. Many capabilities play into the successful management and execution of Quality. This includes for example, the definition, documentation, submission, monitoring and management of quality related activities and tasks as well as the execution of quality tests. The BIOVIA approach will support the FDA mandate for deeper integration of Quality into end-to-end operations to design quality into products and processes as well as foster a quality culture across all areas of an organization from discovery to commercialization.

4. What do you hope the audience will learn from this webinar?

By attending this webinar, I hope the audience will see the true potential impact of eliminating paper from their Quality Testing processes and how that positively affects their bottom line.

Join Gene Tetreault in BIOVIA’s Webinar ‘Building Compliance and Operational Excellence into your Quality Lab Operations’ on 19 May at 4pm London/11am New York

John Giles, Jr., Director, Covance Market Access Services

John GilesJohn is a Director in Managed Market Services and leads the business development in Covance Managed Market Services business. He has been in various roles for 25 years in the healthcare industry, specializing in a wide variety of data solutions, account management, analytics and enterprise wide systems. 

He has worked for Roche and Johnson & Johnson in sales and marketing, contracting and sales operations. Before joining Covance, John was an Account Executive for IMS Health selling the portfolio of products and services. At IMS Health, John worked closely with Fortune 50 companies to help create marketing strategies and create solutions to wide variety of issues.

1. Why did you decide to do a webinar with us?

BRW is the gold standard of webinar vendors.

2. What will the audience gain from attending your webinar?

A better understanding of the 340B Program as it continues to evolve and raise concerns.

3. How did you get into the industry and what do you most enjoy about your role?

I started in the pharma industry in 1991 with Roche as a sales rep, then moved into management in sales operations in various roles on both sides , manufacturing and vendor.  What I enjoy most about my role is guiding clients through the complex healthcare issues that exist and continue to grow even more complex.

4. What are you hoping to achieve in the future in your personal and professional life?

To continue to be a constant learner. Life and the market are always evolving. I want to continue to identify the patterns and trends and stay current with the technology as the healthcare system undergoes rapid transformation.

5. What would someone be surprised to know about you? 

I have been skydiving and scuba diving.

John will be presenting Covance’s webinar ‘Challenges of Complying with 340B Program‘ with Steve Madina, Vice President, Covance Market Access Services on the 30th April at 1pm New York/6pm London. You can register for the webinar here

 

Andrea Mühleis, Product Specialist, Kjeldahl & Dumas Solutions, BÜCHI Labortechnik AG

Andrea MühleisAndrea Mühleis is the Product Specialist for Kjeldahl & Dumas Solutions at BÜCHI Labortechnik AG in Switzerland. She graduated at the University of Hohenheim in Germany as an engineer for food technology. She was formerly the development chemist at BÜCHI Labortechnik AG responsible for the development of the Kjeldahl and Dumas instruments.

  1. Why did you decide to do a webinar with us?

This is the first time we are cooperating with Business Review Webinars. We were searching for a competent partner to promote our webinar and topics to the right target audience. I’m really looking forward to it!

  1. How did you get into the industry?

I was always interested in science. After school I decided to study food technology because it seemed to be the perfect combination of biology, chemistry and physics with practical applications.  After my degree I didn’t want to join the food industry because the analytical practical part in the laboratory during my studies was more fascinating for me. When I applied for my first job as development chemist for BÜCHI I already knew at least five different BÜCHI instruments, some of them older than me… but still working perfectly!

  1. What has been the best moment in your career?

Good question; I think there has not been a “best moment” for me so far – it’s more about the positive feedback I get from my daily work and working with good colleagues who make me laugh during a coffee break. Additionally, it always leaves me with a good feeling when people, after a training session at BÜCHI, understand what we are doing and how we can simplify their work in the lab.

  1. Where is your favourite place in the world and why?

I really love to travel and there are so many beautiful spots! One of the most impressive places I have ever been to was Machu Picchu in Peru.  To visit the ruins of this ancient culture in the mountains is absolutely special. When I was there suddenly the weather changed and we were standing between the ruin surrounded by clouds and there was lightning in the air which actually made our hair stand-up at the end!

  1. What’s the most useful thing someone has ever taught you?

From my educational point of view, I think the most useful thing I ever learned was the simple mathematical “rule of three” for cross-multiplication, I need it daily! And of course when my father told me how to change a flat tyre.

Andrea is hosting BÜCHI Labortechnik AG’s webinar ‘Unattended and flexible protein determination in food samples‘ with Jon Griffin, Public Analyst, Kent Scientific Services on the 22nd April at 10am New York/3pm London/4pm Bern. You can register for the webinar here.

Rick Chan, PhD, Vice President, Research & Development at LTS Lohmann Therapy Systems

Rick Chanl

Dr Rick Chan is a pharmacist, who obtained his postgraduate degrees from the University of London. He joined LTS in 2011 and is responsible for oral thin film R&D work globally. Prior to LTS, he was a Senior Director with GSK and its legacy companies in Product Development, New Product Research and New Opportunities, most notably in Pain Management and Smoking Cessation. He has worked internationally in Australia, Asia Pacific, Japan, and in the USA, and was a member of the GSK Drug Delivery Technology Steering Committee.

1. Why did you decide to do a webinar with Business Review Webinars?

It is a broader reach to a larger audience around the globe. This makes dissemination of information more effective. Apart from that, my business partner thinks it is a great idea!

2. What will the audience gain from attending your webinar?

Understand the potential applications of oral thin film and their suitability  when evaluating drug delivery systems for their molecules.

3. What’s your favourite thing about presenting to a live audience?

Engagement and interaction

4. Who or what inspired you to get into the industry?

I worked in community and hospital pharmacy in the summer vacations during my undergraduate years. I found them rewarding. When I was about to finish my final year of study, I was encouraged to apply and won an scholarship for my MSc in Pharmaceutical Technology at  University of London. I was privileged to have met my mentors – Prof Neiton Pilpel and Prof Mike Newton; both of whom became my academic supervisors at different stages in my PhD study. As they say, the rest is history!

5. What one item would you take with you to a desert island?

My guitar and sheet music.

Join Rick who will be presenting in LTS Lohmann Therapy Systems webinar ‘Oral Thin Films: New opportunities for oral drug delivery?‘ on 5th May at 3PM London/10AM New York.

Prof. Dr. R.H.N. van Schaik, PhD, Professor in Pharmacogenetics, Department of Clinical Chemistry

Prof. Dr. R.H.N. van Schaik

Ron H.N. van Schaik, PhD is a registered European Specialist Laboratory Medicine (2003) and Full Professor Pharmacogenetics (2013). He is working at the department of Clinical Chemistry (AKC) at the Erasmus University Medical Center (Erasmus MC) in Rotterdam since 1998. He studied chemistry at Utrecht University (specializations Biochemistry, Clinical Chemistry and Molecular Biology) and received his PhD in 1992. He was trained in molecular biology at Cold Spring Harbor Laboratories in New York. From 1992, he worked as post-doc at the Erasmus University (Dept. Endocrinology & Reproduction) and the Academic Hospital Rotterdam (Dept. Pathology, Dept. Clinical Chemistry) on translational research involving molecular biological testing. Currently, he is head of the AKC unit Specialized Research & Development (BO&O) and of the Pharmacogenetics Core Laboratory AKC.

Prof. van Schaik leads a research group on pharmacogenetics, in which the translation to implementation for patient diagnostics is the main topic. Current lines of research include Transplantation/immunosuppression, Oncology, Psychiatry, Pain treatment, anticoagulation and HIV. He has published over 150 articles on pharmacogenetics, and participates in national (NVKC, KNMP) and international (AACC, IFCC, IATDMCT, ESPT, IUPHAR, EMA) advisory committees on this topic. As a second line of research, he is involved in studies on new markers for the detection of prostate cancer.

1. Why did you decide to do a webinar with Business Review Webinars?

I have been asked to be a speaker for this webinar on behalf of Luminex, as we are in close cooperation for pharmacogenetics

2. How did you get into the industry?

I studied biochemistry in Utrecht and learned molecular biology and wanted to focus on clinical use. Pharmacogenetics was just emerging so I started working on that during my residency at the department of clinical chemistry at Erasmus MC Rotterdam.

3. What do you most enjoy about your role?

Implementing new knowledge for a better cure of patients.

4. What has been your best holiday and where would you recommend visiting?

Sardegna, because of the weather, nature, kind people, good food and relaxed atmosphere.

5. What motivates you?

Improving people’s health.

Join Prof. Dr. R.H.N. van Schaik in Luminex’s Webinar ‘Pharmacogenetics in Clinical Practice: Can we still do without?’ on 6th May at 3PM London/10AM New York.